The Zhitong Finance App learned that before the US stock market on Tuesday, Johnson & Johnson (JNJ.US) announced better-than-expected results for the third quarter of 2026 and raised revenue and profit guidelines for the full year 2026. Financial reports show that Johnson & Johnson's third-quarter sales increased 5.9% year over year to US$25.4 billion, in line with general market expectations. In terms of profit, GAAP net profit plummeted 95.9% year over year to US$210 million. After dilution, earnings per share were only 0.09 US dollars (2.12 US dollars in the same period last year), mainly due to one-time pre-tax expenses related to the proposed settlement of the US$5,519 billion talc lawsuit.
Zhitongcaijing · 2d ago
Share
Listen to the news
The Zhitong Finance App learned that before the US stock market on Tuesday, Johnson & Johnson (JNJ.US) announced better-than-expected results for the third quarter of 2026 and raised revenue and profit guidelines for the full year 2026. Financial reports show that Johnson & Johnson's third-quarter sales increased 5.9% year over year to US$25.4 billion, in line with general market expectations. In terms of profit, GAAP net profit plummeted 95.9% year over year to US$210 million. After dilution, earnings per share were only 0.09 US dollars (2.12 US dollars in the same period last year), mainly due to one-time pre-tax expenses related to the proposed settlement of the US$5,519 billion talc lawsuit.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending